FI67221C - Foerfarande foer framstaellning av farmakologiskt aktiva tiadiazol- och oxadiazoltetrahydroisokinolinfoereningar - Google Patents

Foerfarande foer framstaellning av farmakologiskt aktiva tiadiazol- och oxadiazoltetrahydroisokinolinfoereningar Download PDF

Info

Publication number
FI67221C
FI67221C FI802112A FI802112A FI67221C FI 67221 C FI67221 C FI 67221C FI 802112 A FI802112 A FI 802112A FI 802112 A FI802112 A FI 802112A FI 67221 C FI67221 C FI 67221C
Authority
FI
Finland
Prior art keywords
tetrahydroisoquinoline
acetyl
thiadiazole
amino
hydrochloric acid
Prior art date
Application number
FI802112A
Other languages
English (en)
Finnish (fi)
Other versions
FI802112A (fi
FI67221B (fi
Inventor
William Edward Bondinell
Gerald Robert Girard
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of FI802112A publication Critical patent/FI802112A/fi
Application granted granted Critical
Publication of FI67221B publication Critical patent/FI67221B/fi
Publication of FI67221C publication Critical patent/FI67221C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
FI802112A 1979-07-02 1980-07-01 Foerfarande foer framstaellning av farmakologiskt aktiva tiadiazol- och oxadiazoltetrahydroisokinolinfoereningar FI67221C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5434379A 1979-07-02 1979-07-02
US5434379 1979-07-02

Publications (3)

Publication Number Publication Date
FI802112A FI802112A (fi) 1981-01-03
FI67221B FI67221B (fi) 1984-10-31
FI67221C true FI67221C (fi) 1985-02-11

Family

ID=21990408

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802112A FI67221C (fi) 1979-07-02 1980-07-01 Foerfarande foer framstaellning av farmakologiskt aktiva tiadiazol- och oxadiazoltetrahydroisokinolinfoereningar

Country Status (30)

Country Link
EP (1) EP0023761B1 (es)
JP (1) JPS5610192A (es)
KR (1) KR840000396B1 (es)
AR (1) AR225925A1 (es)
AT (1) ATE6515T1 (es)
AU (1) AU531641B2 (es)
BG (1) BG51250A3 (es)
CA (1) CA1129415A (es)
CS (1) CS215064B2 (es)
DD (1) DD151750A5 (es)
DE (1) DE3066826D1 (es)
DK (1) DK151029C (es)
ES (1) ES492971A0 (es)
FI (1) FI67221C (es)
GR (1) GR69206B (es)
HU (1) HU179382B (es)
IE (1) IE50290B1 (es)
IL (1) IL60426A (es)
IN (1) IN160542B (es)
MX (1) MX6317E (es)
NO (1) NO801951L (es)
NZ (1) NZ194156A (es)
PH (1) PH17042A (es)
PL (2) PL127098B1 (es)
PT (1) PT71458A (es)
RO (1) RO79707A (es)
SU (1) SU1072809A3 (es)
YU (1) YU171180A (es)
ZA (1) ZA802987B (es)
ZW (1) ZW14680A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988339A (en) * 1974-02-08 1976-10-26 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase
US3939164A (en) * 1974-02-08 1976-02-17 Smithkline Corporation 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds

Also Published As

Publication number Publication date
IL60426A0 (en) 1980-09-16
AR225925A1 (es) 1982-05-14
CS215064B2 (en) 1982-07-30
IE801352L (en) 1981-01-02
MX6317E (es) 1985-04-01
HU179382B (en) 1982-10-28
IE50290B1 (en) 1986-03-19
SU1072809A3 (ru) 1984-02-07
ES8105736A1 (es) 1981-06-01
ATE6515T1 (de) 1984-03-15
IN160542B (es) 1987-07-18
FI802112A (fi) 1981-01-03
DE3066826D1 (en) 1984-04-12
PL127098B1 (en) 1983-09-30
DK274280A (da) 1981-01-03
CA1129415A (en) 1982-08-10
BG51250A3 (en) 1993-03-15
ZA802987B (en) 1981-05-27
DD151750A5 (de) 1981-11-04
KR830002791A (ko) 1983-05-30
YU171180A (en) 1983-09-30
NZ194156A (en) 1983-03-15
PL230619A1 (es) 1981-12-11
AU531641B2 (en) 1983-09-01
PL225377A1 (es) 1981-08-21
ES492971A0 (es) 1981-06-01
EP0023761B1 (en) 1984-03-07
DK151029C (da) 1988-03-07
KR840000396B1 (ko) 1984-03-30
EP0023761A1 (en) 1981-02-11
PH17042A (en) 1984-05-17
NO801951L (no) 1981-01-05
FI67221B (fi) 1984-10-31
GR69206B (es) 1982-05-07
IL60426A (en) 1984-03-30
RO79707A (ro) 1982-08-17
JPS5610192A (en) 1981-02-02
DK151029B (da) 1987-10-12
PT71458A (en) 1980-07-01
AU5967780A (en) 1981-01-15
ZW14680A1 (en) 1980-09-24

Similar Documents

Publication Publication Date Title
EP1129093B1 (en) Pyrazolopyrimidinone derivatives for the treatment of impotence
FI79846B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla heteroaromatiska aminderivat.
Bruno et al. New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening
IE871767L (en) PYRROLO £1,2-c| THIAZOLE DERIVATIVES
PL91610B1 (es)
US4128666A (en) 4 AND 5-Halo substituted 2-indanamine compounds
EP0189818A1 (en) Isoquinoline thromboxane synthetase inhibitors
FI67221C (fi) Foerfarande foer framstaellning av farmakologiskt aktiva tiadiazol- och oxadiazoltetrahydroisokinolinfoereningar
PL144341B1 (en) Method of obtaining new heterocyclic compounds
US4352809A (en) Method of producing alpha2 antagonism
FI68399B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-amino-3-nitropyrrolderivat
FI64939B (fi) Foerfarande foer framstaellning av en 10,11-dihydro-5h-dibenso(a,d)cyklohepten-5,10-imin
NZ222805A (en) Triazine derivatives and pharmaceutical compositions
US4192888A (en) Pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase
US4093725A (en) (3-Alkylamino-2-hydroxypropoxy)-1-hydrazinophthalazines
US4228170A (en) 7- and/or 8-Sulfur substituted 1,2,3,4-tetrahydroisoquinoline compounds
US4258049A (en) Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines
US4539402A (en) Quinazolinone derivatives
US4242346A (en) Bis-2N-alkylene tetrahydroisoquinoline compounds
US4272531A (en) 3,3'-Bis-methylene-1,3-benzo-thiazine compounds
US3560512A (en) 3-substituted-2,1-benzisothiazoline-2,2-dioxides
US4576954A (en) Anti-rheumatic 5-(substituted amino)-1,2-dithiol-3-one compounds and their use
CS228929B2 (cs) Způsob výroby ve vodě rozpustných solí N-(2-pyridyl)-2-methyl-4-hydroxy-2H-l,2-benzothiazin-3-karboxamid-l,l-dioxidu
EP0172692B1 (en) Hexahydroindolizine compounds, pharmaceutical compositions and methods and intermediates
FI89363C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla tieno(3',4'-4,5)imidazo(2,1-b)tiazolderivat

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SMITHKLINE BECKMAN CORPORATION